Washington/Oregon Inland Tree Mixture is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Populus Tremuloides Pollen; Populus Balsamifera Subsp. Trichocarpa Pollen; Acer Negundo Pollen; Pinus Contorta Pollen; Fraxinus Latifolia Pollen; Alnus Rhombifolia Pollen; Betula Occidentalis Pollen; Pinus Ponderosa Pollen; Salix Lucida Ssp. Lasiandra Pollen.
Product ID | 49288-0589_13c9eea1-38b5-472b-b735-a814ca886718 |
NDC | 49288-0589 |
Product Type | Human Prescription Drug |
Proprietary Name | Washington/Oregon Inland Tree Mixture |
Generic Name | Washington/oregon Inland Tree Mixture |
Dosage Form | Injection, Solution |
Route of Administration | INTRADERMAL; SUBCUTANEOUS |
Marketing Start Date | 1996-07-12 |
Marketing Category | BLA / BLA |
Application Number | BLA102223 |
Labeler Name | Antigen Laboratories, Inc. |
Substance Name | POPULUS TREMULOIDES POLLEN; POPULUS BALSAMIFERA SUBSP. TRICHOCARPA POLLEN; ACER NEGUNDO POLLEN; PINUS CONTORTA POLLEN; FRAXINUS LATIFOLIA POLLEN; ALNUS RHOMBIFOLIA POLLEN; BETULA OCCIDENTALIS POLLEN; PINUS PONDEROSA POLLEN; SALIX LUCIDA SSP. LASIANDRA POLLEN |
Active Ingredient Strength | 0 g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL |
Pharm Classes | Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS] |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 1996-07-12 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA102223 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1996-07-12 |
Inactivation Date | 2019-10-21 |
Marketing Category | BLA |
Application Number | BLA102223 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1996-07-12 |
Inactivation Date | 2019-10-21 |
Marketing Category | BLA |
Application Number | BLA102223 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1996-07-12 |
Inactivation Date | 2019-10-21 |
Marketing Category | BLA |
Application Number | BLA102223 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1996-07-12 |
Inactivation Date | 2019-10-21 |
Marketing Category | BLA |
Application Number | BLA102223 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1996-07-12 |
Inactivation Date | 2019-10-21 |
Ingredient | Strength |
---|---|
POPULUS TREMULOIDES POLLEN | .0056 g/mL |